Evidence map›Paper›PMID 22820329›Full record

ArticleApplied and environmental microbiology2012

Mycobacterial shuttle vectors designed for high-level protein expression in infected macrophages.

Jennifer L Eitson, Jennifer J Medeiros, Ashley R Hoover, Shashikant Srivastava, Kole T Roybal, José A Aínsa, Eric J Hansen, Tawanda Gumbo, Nicolai S C van Oers

Open access · bronzeAbstract readEvaluation Study
In one paragraph

Article in Applied and environmental microbiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Construction of aACS omega · 2025
    Article
  2. Article
  3. Article
  4. The Biological and Clinical Aspects of a Latent Tuberculosis Infection.Tropical medicine and infectious disease · 2022
    Review
  5. Article
  6. Article
  7. sncRNA-1 Is a Small Noncoding RNA Produced byFrontiers in microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Jennifer L EitsonThe Department of Immunology, The University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Jennifer J Medeiros
Ashley R Hoover
Shashikant Srivastava
Kole T Roybal
José A Aínsa
Eric J Hansen
Tawanda Gumbo
Nicolai S C van Oers
The University of Texas Southwestern Medical Center · USUniversidad de Zaragoza · ES

Funding

Efflux pump inhibitors to reduce duration of antituberculosis therapyDP2OD001886 · OD · UT SOUTHWESTERN MEDICAL CENTER · PI GUMBO, TAWANDA · 2007 to 2007
$2.4M
NIH HHS 1 DP2 OD001886NIH HHS DP2 OD001886
6 · The paper itself

Abstract

Mycobacterial shuttle vectors contain dual origins of replication for growth in both Escherichia coli and mycobacteria. One such vector, pSUM36, was re-engineered for high-level protein expression in diverse bacterial species. The modified vector (pSUM-kan-MCS2) enabled green fluorescent protein expression in E. coli, Mycobacterium smegmatis, and M. avium at levels up to 50-fold higher than that detected with the parental vector, which was originally developed with a lacZα promoter. This high-level fluorescent protein expression allowed easy visualization of M. smegmatis and M. avium in infected macrophages. The M. tuberculosis gene esat-6 was cloned in place of the green fluorescence protein gene (gfp) to determine the impact of ESAT-6 on the innate inflammatory response. The modified vector (pSUM-kan-MCS2) yielded high levels of ESAT-6 expression in M. smegmatis. The ability of ESAT-6 to suppress innate inflammatory pathways was assayed with a novel macrophage reporter cell line, designed with an interleukin-6 (IL-6) promoter-driven GFP cassette. This stable cell line fluoresces in response to diverse mycobacterial strains and stimuli, such as lipopolysaccharide. M. smegmatis clones expressing high levels of ESAT-6 failed to attenuate IL-6-driven GFP expression. Pure ESAT-6, produced in E. coli, was insufficient to suppress a strong inflammatory response elicited by M. smegmatis or lipopolysaccharide, with ESAT-6 itself directly activating the IL-6 pathway. In summary, a pSUM-protein expression vector and a mammalian IL-6 reporter cell line provide new tools for understanding the pathogenic mechanisms deployed by various mycobacterial species.

Indexed as

Gene ExpressionGenetic VectorsAntigens, BacterialBacterial ProteinsEscherichia coliFluorescenceGenes, ReporterGenetics, MicrobialGreen Fluorescent ProteinsImmune EvasionImmune ToleranceMacrophagesMolecular BiologyMycobacteriumRecombinant ProteinsVirulence FactorsAntigens, BacterialBacterial ProteinsESAT-6 protein, Mycobacterium tuberculosisGreen Fluorescent ProteinsRecombinant ProteinsVirulence Factors

Identifiers

PMID22820329
PMCPMC3457510
OpenAlexW2052717571

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.